Discovery of antivirals against smallpox executive summary

To explore ways to encourage the broader academic biology community and the commercial sector to participate in the process of discovering new smallpox antiviral drugs, The National Academies held a brainstorming workshop in Washington, D.C. on June 15-16, 2003. The 30 workshop participants in atten...

Full description

Bibliographic Details
Corporate Author: National Research Council (U.S.) Committee on Transforming Biological Information into New Therapies: A Strategy for Developing Antiviral Drugs for Smallpox
Format: eBook
Language:English
Published: Washington, D.C. National Academies Press c2004, 2004
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02029nam a2200229 u 4500
001 EB002010906
003 EBX01000000000000001173805
005 00000000000000.0
007 tu|||||||||||||||||||||
008 220201 r ||| eng
245 0 0 |a Discovery of antivirals against smallpox  |h Elektronische Ressource  |b executive summary  |c Institute of Medicine (U.S.) and National Research Council (U.S.) Committee on Transforming Biological Information into New Therapies: A Strategy for Developing Antiviral Drugs for Smallpox 
260 |a Washington, D.C.  |b National Academies Press  |c c2004, 2004 
300 |a 1 online resource 
653 |a Smallpox Vaccine 
653 |a United States 
653 |a Smallpox / prevention & control 
710 2 |a National Research Council (U.S.)  |b Committee on Transforming Biological Information into New Therapies: A Strategy for Developing Antiviral Drugs for Smallpox 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK83490  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a To explore ways to encourage the broader academic biology community and the commercial sector to participate in the process of discovering new smallpox antiviral drugs, The National Academies held a brainstorming workshop in Washington, D.C. on June 15-16, 2003. The 30 workshop participants in attendance included several pox virologists and numerous experts in cell biology, biochemistry, and structural biology, as well as representatives from government, the biotechnology industry, and pharmaceutical companies. Following the meeting, The National Academies established the Committee on Transforming Biological Information into New Therapies to prepare a report that describes important scientific questions for research and suggests ways to expedite the discovery of smallpox antiviral drugs. The report has two main parts: I. Scientific Opportunities, and II. Incentives, Logistics, and Policies